Reisterstown, MD, United States of America

Mark Schenerman

USPTO Granted Patents = 5 

Average Co-Inventor Count = 4.2

ph-index = 3

Forward Citations = 32(Granted Patents)


Company Filing History:


Years Active: 2009-2018

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Mark Schenerman

Introduction

Mark Schenerman is a notable inventor based in Reisterstown, MD (US). He has made significant contributions to the field of medical research, particularly in the development of vaccines for respiratory syncytial virus (RSV). With a total of 5 patents to his name, Schenerman's work has the potential to impact public health positively.

Latest Patents

One of Schenerman's latest patents focuses on antibodies against and methods for producing vaccines for respiratory syncytial virus. This invention relates to novel RSV F peptides and compositions that comprise them. It also includes methods for evaluating anti-RSV antibody binding to these F peptides. Furthermore, the invention provides antibodies that immunospecifically bind to an F peptide, along with methods and protocols for administering these F peptides and/or antibodies. These advancements aim to prevent, neutralize, and treat RSV infections, as well as ameliorate symptoms associated with such infections.

Career Highlights

Mark Schenerman is currently associated with Medimmune Limited, a company known for its innovative approaches in the biopharmaceutical sector. His work at Medimmune has allowed him to focus on developing solutions that address critical health challenges.

Collaborations

Throughout his career, Schenerman has collaborated with esteemed colleagues, including Guillermo Tous and Jose Casas-Finet. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Mark Schenerman's contributions to the field of vaccine development, particularly for respiratory syncytial virus, highlight his role as a significant inventor. His work continues to pave the way for advancements in medical research and public health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…